ArticleAnnals of translational medicine2022

A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapy.

Zihao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.